Heron Therapeutics (HRTX) PT Lowered to $52 at Needham & Company
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Pacira Pharma (PCRX) Strength Tied to News of Heron's (HRTX) CRL
May 1, 2019 8:39 AM EDTPacira Pharma (NASDAQ: PCRX) strength Wednesday was tied to news peer Heron Therapeutics (NASDAQ: HRTX) received a CRL for HTX-011 for management of postoperative pain.
Pacira Pharma shares climbed 15%, while Heron Therapeutics declined 29%.
... MoreHeron Therapeutics (HRTX) to Resume Trading at 8:30 am ET
May 1, 2019 8:08 AM EDTHeron Therapeutics (NASDAQ: HRTX) to Resume Trading at 8:30 am ET
... MoreHeron Therapeutics (HRTX) Receives CRL For HTX-011 For Management of Postoperative Pain
May 1, 2019 8:03 AM EDTHeron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that it received a Complete Response Letter (CRL) from the... More
